Comparative Effectiveness of Initial LAMA versus LABA in COPD: Real-World Cohort Study

References

• Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176(6):532–555. DOI:10.1164/rccm.200703-456SO
   PubMed Web of Science ®Google Scholar
• Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–2128. DOI:10.1016/S0140-6736(12)61728-0
   PubMed Web of Science ®Google Scholar
• Global strategy for the diagnosis, management, and prevention of Chronic Obstructive Pulmonary Disease. 2019. Report http://goldcopdorg/gold-2019-global-strategy-diagnosis-management-prevention-copd/2019.
   Google Scholar
• Vogelmeier C, Hederer B, Glaab T, et al. Tiotropium versus salmeterol for the prevention of exacerbations of COPD. N Engl J Med. 2011;364(12):1093–1103. DOI:10.1056/NEJMoa1008378
   PubMed Web of Science ®Google Scholar
• Decramer ML, Chapman KR, Dahl R, et al. Once-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group study. Lancet Respir Med. 2013;1(7):524–533. DOI:10.1016/S2213-2600(13)70158-9
   PubMed Web of Science ®Google Scholar
• Gershon A, Croxford R, To T, et al. Comparison of inhaled long-acting β-agonist and anticholinergic effectiveness in older patients with chronic obstructive pulmonary disease: a cohort study. Ann Intern Med. 2011;154(9):583–592. DOI:10.7326/0003-4819-154-9-201105030-00003
   PubMed Web of Science ®Google Scholar
• Herrett E, Gallagher AM, Bhaskaran K, et al. Data resource profile: Clinical Practice Research Datalink (CPRD). Int J Epidemiol. 2015;44(3):827–836. DOI:10.1093/ije/dyv098
   PubMed Web of Science ®Google Scholar
• Herrett E, Thomas SL, Schoonen WM, et al. Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol. 2010;69(1):4–14. DOI:10.1111/j.1365-2125.2009.03537.x
   PubMed Web of Science ®Google Scholar
• Wolf A, Dedman D, Campbell J, et al. Data resource profile: Clinical Practice Research Datalink (CPRD) aurum. Int J Epidemiol. 2019;48(6):1740–1740g. DOI:10.1093/ije/dyz034
   PubMed Web of Science ®Google Scholar
• Jick SS, Kaye JA, Vasilakis-Scaramozza C, et al. Validity of the general practice research database. Pharmacotherapy. 2003;23(5):686–689. DOI:10.1592/phco.23.5.686.32205
   PubMed Web of Science ®Google Scholar
• Quint JK, Mullerova H, DiSantostefano RL, et al. Validation of chronic obstructive pulmonary disease recording in the Clinical Practice Research Datalink (CPRD-GOLD). BMJ Open. 2014;4(7):e005540. DOI:10.1136/bmjopen-2014-005540
   PubMed Web of Science ®Google Scholar
• Suissa S, Dell'Aniello S, Ernst P. Concurrent use of long-acting bronchodilators in COPD and the risk of adverse cardiovascular events. Eur Respir J. 2017;49(5):1602245. DOI:10.1183/13993003.02245-2016
   PubMed Web of Science ®Google Scholar
• Suissa S, Dell'Aniello S, Ernst P. Long-acting bronchodilator initiation in COPD and the risk of adverse cardiopulmonary events: a population-based comparative safety study. Chest. 2017;151(1):60–67. DOI:10.1016/j.chest.2016.08.001
   PubMed Web of Science ®Google Scholar
• Suissa S, Dell'Aniello S, Ernst P. Comparative effectiveness of LABA–ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study. Lancet Respir Med. 2018;6(11):855–862. DOI:10.1016/S2213-2600(18)30368-0
   PubMed Web of Science ®Google Scholar
• Suissa S, Dell'Aniello S, Ernst P. Comparative effectiveness and safety of LABA–LAMA vs LABA–ICS treatment of COPD in real-world clinical practice . Chest. 2019;155(6):1158–1165. DOI:10.1016/j.chest.2019.03.005
   PubMed Web of Science ®Google Scholar
• Suissa S, Dell'Aniello S, Ernst P. Comparative effects of LAMA–LABA–ICS vs LAMA–LABA for COPD: cohort study in real-world clinical practice. Chest. 2020;157(4):846–855. DOI:10.1016/j.chest.2019.11.007
   PubMed Web of Science ®Google Scholar
• Ray WA. Evaluating medication effects outside of clinical trials: new-user designs. Am J Epidemiol. 2003;158(9):915–920. DOI:10.1093/aje/kwg231
   PubMed Web of Science ®Google Scholar
• Suissa S, Moodie EE, Dell'Aniello S. Prevalent new-user cohort designs for comparative drug effect studies by time-conditional propensity scores. Pharmacoepidemiol Drug Saf. 2017;26(4):459–468. DOI:10.1002/pds.4107
   PubMed Web of Science ®Google Scholar
• Desai RJ, Franklin JM. Alternative approaches for confounding adjustment in observational studies using weighting based on the propensity score: a primer for practitioners. BMJ. 2019;367:l5657. DOI:10.1136/bmj.l5657
   PubMed Web of Science ®Google Scholar
• Rothnie KJ, Müllerová H, Hurst JR, et al. Validation of the recording of acute exacerbations of COPD in UK primary care electronic healthcare records. Plos One. 2016;11(3):e0151357. DOI:10.1371/journal.pone.0151357
   PubMed Web of Science ®Google Scholar
• Rothnie KJ, Müllerová H, Thomas SL, et al. Recording of hospitalizations for acute exacerbations of COPD in UK electronic health care records. Clin Epidemiol. 2016;8:771–782. DOI:10.2147/CLEP.S117867
   PubMed Web of Science ®Google Scholar
• Meropol SB, Metlay JP. Accuracy of pneumonia hospital admissions in a primary care electronic medical record database. Pharmacoepidemiol Drug Saf. 2012;21(6):659–665. DOI:10.1002/pds.3207
   PubMed Web of Science ®Google Scholar
• Rothnie KJ, Chandan JS, Goss HG, et al. Validity and interpretation of spirometric recordings to diagnose COPD in UK primary care. Int J Chron Obstruct Pulmon Dis. 2017;12:1663–1668. DOI:10.2147/COPD.S133891
   PubMed Web of Science ®Google Scholar
• Rebordosa C, Plana E, Aguado J, et al. GOLD assessment of COPD severity in the Clinical Practice Research Datalink (CPRD). Pharmacoepidemiol Drug Saf. 2019;28(2):126–133. DOI:10.1002/pds.4448
   PubMed Web of Science ®Google Scholar
• Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations . Eur Respir J. 2012;40(6):1324–1343. DOI:10.1183/09031936.00080312
   PubMed Web of Science ®Google Scholar
• Nici L, Mammen MJ, Charbek E, et al. Pharmacologic management of chronic obstructive pulmonary disease. An OFFICIAL American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2020;201(9):e56–e69. DOI:10.1164/rccm.202003-0625ST
   PubMed Web of Science ®Google Scholar